Michael J. McElhaugh

Chief Business Officer, Arbutus Biopharma.

Companies

Arbutus BiopharmaBoard member Feb 5, 2024 to Feb 19, 2025¹
Arbutus BiopharmaChief executive officer Feb 5, 2024 to Feb 19, 2025¹
Arbutus BiopharmaPresident Feb 5, 2024 to Feb 19, 2025¹
Arbutus BiopharmaChief Business Officer Dec 21, 2018 to Feb 3, 2023²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Arbutus Biopharma ABUS1,658,003 shares³$7.1M at $4.29Feb 14, 2025

As of each latest filing. The line shows shares held over time.

Recent filings

Feb 14, 2025Granted 177,000 shares of Arbutus Biopharma³
Feb 4, 2025Sold 23,790 shares at $3.28 of Arbutus Biopharma⁴
Feb 2, 2024Sold 10,164 shares at $2.31 of Arbutus Biopharma⁵
Feb 1, 2024Granted 123,800 shares of Arbutus Biopharma⁵
Feb 1, 2023Granted 83,700 shares of Arbutus Biopharma⁶

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARArbutus Biopharma, Board member
2
SEC EDGARArbutus Biopharma, Chief Business Officer
3
SEC EDGARArbutus Biopharma shares after the filing of Feb 14, 2025
4
SEC EDGARForm 4 filed Feb 5, 2025
5
SEC EDGARForm 4 filed Feb 5, 2024
6
SEC EDGARForm 4 filed Feb 3, 2023